Talawar Therapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.talawartx.comRevenue
<$5 MillionIndustry
About Talawar Therapeutics
Talawar Therapeutics is a biotechnology company developing potentially best-in-class bispecific antibodies that pair independent disease drivers in a single therapy, targeting pathways that work together for greater, more durable impact. Our lead program, TALA-125, is a novel anti-IL-13 x anti-IL-18 bispecific that combines two clinically validated, largely orthogonal mechanisms designed to shatter the current limitations of existing treatments — with broad applicability across first-line patients and those who have failed previous therapies.Explore more
SIC Code 28,283NAICS Code 32,325Show moreTalawar Therapeutics Org Chart
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Talawar Therapeutics
Sign Up For FreeTo access detailed company insights
Talawar Therapeutics is a biotechnology company developing potentially best-in-class bispecific antibodies that pair independent disease drivers in a single therapy, targeting pathways that work together for greater, more durable impact. Our lead program, TALA-125, is a novel anti-IL-13 x anti-IL-18 bispecific that combines two clinically validated... Read More
